Here’s what investors need to know about ADMP stock rising today. The latest news concerning Adamis Pharma is that its SYMJEPI Injection products are being offered at a special price to members of the ...

It’s an unusual day for Adamis Pharmaceuticals (NASDAQ:ADMP) stock traders, to say the least. That’s because the company recently announced its intent to acquire DMK Pharmaceuticals. Adamis’ ...

The market expects Adamis Pharmaceuticals (ADMP) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2018. This widely-known ...

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) shares gained more than 50% today following the approval of its pre-filled single dose syringe for the emergency treatment of allergic reactions. Last ...

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At ...

Adamis Pharmaceutical (NASDAQ: ADMP) stock has not done well for investors these past few years. 89% value destruction in the past 12 months, 99% in the past 5 years, 26% down just on the one day, ...

Adamis Pharmaceuticals (NASDAQ: ADMP) stock is back down 40% this morning, After yesterday’s up to 480% rise in ADMP stock that is, although the close was at 170% up. The net of this - at least so far ...

Adamis Pharmaceuticals (ADMP) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...

On Monday, shares of Adamis Pharmaceuticals Corp. ADMP are crashing, down over 50% in morning trading after news broke that the Food and Drug Administration (FDA) sent the company a Complete Response ...